40
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      MRI of the lung (3/3)—current applications and future perspectives

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          MRI of the lung is recommended in a number of clinical indications. Having a non-radiation alternative is particularly attractive in children and young subjects, or pregnant women.

          Methods

          Provided there is sufficient expertise, magnetic resonance imaging (MRI) may be considered as the preferential modality in specific clinical conditions such as cystic fibrosis and acute pulmonary embolism, since additional functional information on respiratory mechanics and regional lung perfusion is provided. In other cases, such as tumours and pneumonia in children, lung MRI may be considered an alternative or adjunct to other modalities with at least similar diagnostic value.

          Results

          In interstitial lung disease, the clinical utility of MRI remains to be proven, but it could provide additional information that will be beneficial in research, or at some stage in clinical practice. Customised protocols for chest imaging combine fast breath-hold acquisitions from a “buffet” of sequences. Having introduced details of imaging protocols in previous articles, the aim of this manuscript is to discuss the advantages and limitations of lung MRI in current clinical practice.

          Conclusion

          New developments and future perspectives such as motion-compensated imaging with self-navigated sequences or fast Fourier decomposition MRI for non-contrast enhanced ventilation- and perfusion-weighted imaging of the lung are discussed.

          Main Messages

          MRI evolves as a third lung imaging modality, combining morphological and functional information.

          It may be considered first choice in cystic fibrosis and pulmonary embolism of young and pregnant patients.

          In other cases (tumours, pneumonia in children), it is an alternative or adjunct to X-ray and CT.

          In interstitial lung disease, it serves for research, but the clinical value remains to be proven.

          New users are advised to make themselves familiar with the particular advantages and limitations.

          Related collections

          Most cited references90

          • Record: found
          • Abstract: found
          • Article: not found

          Multidetector computed tomography for acute pulmonary embolism.

          The accuracy of multidetector computed tomographic angiography (CTA) for the diagnosis of acute pulmonary embolism has not been determined conclusively. The Prospective Investigation of Pulmonary Embolism Diagnosis II trial was a prospective, multicenter investigation of the accuracy of multidetector CTA alone and combined with venous-phase imaging (CTA-CTV) for the diagnosis of acute pulmonary embolism. We used a composite reference test to confirm or rule out the diagnosis of pulmonary embolism. Among 824 patients with a reference diagnosis and a completed CT study, CTA was inconclusive in 51 because of poor image quality. Excluding such inconclusive studies, the sensitivity of CTA was 83 percent and the specificity was 96 percent. Positive predictive values were 96 percent with a concordantly high or low probability on clinical assessment, 92 percent with an intermediate probability on clinical assessment, and nondiagnostic if clinical probability was discordant. CTA-CTV was inconclusive in 87 of 824 patients because the image quality of either CTA or CTV was poor. The sensitivity of CTA-CTV for pulmonary embolism was 90 percent, and specificity was 95 percent. CTA-CTV was also nondiagnostic with a discordant clinical probability. In patients with suspected pulmonary embolism, multidetector CTA-CTV has a higher diagnostic sensitivity than does CTA alone, with similar specificity. The predictive value of either CTA or CTA-CTV is high with a concordant clinical assessment, but additional testing is necessary when the clinical probability is inconsistent with the imaging results. Copyright 2006 Massachusetts Medical Society.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study.

            To determine whether a modified Global Initiative on Obstructive Lung Diseases (GOLD) classification of chronic obstructive pulmonary disease (COPD) predicts mortality in a cohort of subjects followed for up to 11 years. We analyzed data from 15,759 adult participants, aged 43-66 years at baseline, in the Atherosclerosis Risk in Communities (ARIC) study. All baseline and follow-up data were available for 15,440 (97.9%) of the initial participants. We classified subjects using a modification of the GOLD criteria for COPD (prebronchodilator forced expiratory volume in 1s (FEV(1)) stratification of disease severity), and added a "restricted" category (FEV(1)/FVC>70% and FVC<80% predicted). We used Cox proportional hazard models to determine the risk of impaired lung function on subsequent mortality, after adjusting for age, race, sex and smoking status. 1242 (8.0%) subjects died by the end of 1997. The overall rate of death was 8.9 per 1000 person years, but varied from 5.4/1000 among normal subjects to 42.9/1000 among subjects with GOLD Stage 3 or 4 COPD. After adjusting for covariates, all GOLD categories, along with the restricted category, predicted a higher risk of death: GOLD Stage 3 or 4, hazard ratio (HR) 5.7, 95% confidence interval (CI) 4.4, 7.3; GOLD Stage 2 HR 2.4, 95% CI 2.0, 2.9; GOLD Stage 1 HR 1.4, 95% CI 1.1, 1.6; GOLD Stage 0 HR 1.5, 95% CI 1.3, 1.8; and restricted HR 2.3, 95% CI 1.9, 2.8. The modified GOLD classification system of COPD predicts mortality in this cohort of middle-aged Americans followed for up to 11 years.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Observations on the Pulmonary Arterial Blood Pressure in the Cat

                Bookmark

                Author and article information

                Contributors
                +49-431-5973153 , juergen.biederer@rad.uni-kiel.de
                Journal
                Insights Imaging
                Insights Imaging
                Insights into Imaging
                Springer-Verlag (Berlin/Heidelberg )
                1869-4101
                15 January 2012
                15 January 2012
                August 2012
                : 3
                : 4
                : 373-386
                Affiliations
                [1 ]Department of Diagnostic Radiology, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Straße. 3, Haus 23, 24105 Kiel, Germany
                [2 ]Clinical Research Imaging Centre, University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ UK
                [3 ]Department of Radiology, University Hospital Würzburg, Josef-Schneider-Straße 2, Haus D31, 97080 Würzburg, Germany
                [4 ]Department of Bioimaging and Radiological Sciences, Catholic University of Rome, Gemelli Hospital, L.go A. Gemelli 8, 00168 Rome, Italy
                [5 ]Division of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
                [6 ]Academic Radiology, Royal Hallamshire Hospital Sheffield, University of Sheffield, Sheffield, S10 2JF UK
                [7 ]Department of Diagnostic and Interventional Radiology, Chest Clinics at University Hospital Heidelberg, Amalienstr. 5, 69126 Heidelberg, Germany
                [8 ]Department of Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
                Article
                142
                10.1007/s13244-011-0142-z
                3481076
                22695943
                a580a7bd-aca8-4e33-b669-2c31ed91ca6c
                © European Society of Radiology 2011
                History
                : 5 August 2011
                : 9 November 2011
                : 17 November 2011
                Categories
                Review
                Custom metadata
                © European Society of Radiology 2012

                Radiology & Imaging
                infiltrate,tumor,functional imaging,pulmonary embolism,cystic fibrosis,magnetic resonance imaging

                Comments

                Comment on this article